BJP Stock Overview
Beit Jala Pharmaceutical Company engages in the manufacture and sale of pharmaceutical products in the Palestinian Authority.
Beit Jala Pharmaceutical Company Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||د.أ2.79|
|52 Week High||د.أ2.90|
|52 Week Low||د.أ2.57|
|1 Month Change||0%|
|3 Month Change||4.89%|
|1 Year Change||8.56%|
|3 Year Change||15.77%|
|5 Year Change||16.25%|
|Change since IPO||82.47%|
Recent News & Updates
|BJP||PS Pharmaceuticals||PS Market|
Return vs Industry: BJP exceeded the PS Pharmaceuticals industry which returned -13.9% over the past year.
Return vs Market: BJP underperformed the PS Market which returned 11.2% over the past year.
|BJP Average Weekly Movement||n/a|
|Pharmaceuticals Industry Average Movement||5.4%|
|Market Average Movement||3.1%|
|10% most volatile stocks in PS Market||6.1%|
|10% least volatile stocks in PS Market||1.8%|
Stable Share Price: Insufficient data to determine BJP's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine BJP's volatility change over the past year.
About the Company
Beit Jala Pharmaceutical Company engages in the manufacture and sale of pharmaceutical products in the Palestinian Authority. The company provides its products in various forms, such as tablets, capsules, powders, oral drops, solutions, suspensions, syrups, creams, gels, lotions, and suppositories. It also offers medicated shampoos; and sterile products, including eye, ear, and nose drops and ointments.
Beit Jala Pharmaceutical Company Fundamentals Summary
|BJP fundamental statistics|
Is BJP overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|BJP income statement (TTM)|
|Cost of Revenue||د.أ7.05m|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||0.14|
|Net Profit Margin||9.95%|
How did BJP perform over the long term?See historical performance and comparison